2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (2203):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-32854
    4-Bromo-3-(trifluoromethyl)aniline
    		99.52%
    4-Bromo-3-(trifluoromethyl)aniline (5-Amino-2-bromobenzotrifluoride) can be used for synthesis of AUY954 (HY-119221) (a S1P1 receptor agonist).
    4-Bromo-3-(trifluoromethyl)aniline
  • HY-W016456
    5-Bromopentanoic acid
    5-Bromopentanoic acid can be used for the synthesis of inhibitors for aminoglycoside resistant bacteria.
    5-Bromopentanoic acid
  • HY-128753
    D-Lyxose
    		98.0%
    D-Lyxose is an endogenous metabolite. D-Lyxose is a rare pentose sugar with significant potential for drug synthesis. D-Lyxose can be used as a starting material for anti-tumor drugs such as alpha galactose ceramide immunostimulants. D-Lyxose can be used as a precursor for L-nucleoside analogs for the development of antiviral drugs. D-Lyxose can be used as a synthetic intermediate for other rare sugars such as L-ribose.
    D-Lyxose
  • HY-W005596
    5-Bromo-3-fluoropicolinic acid
    5-Bromo-3-fluoropicolinic acid (5-Bromo-3-fluoropyridine-2-carboxylic acid) is a drug synthesis intermediate that can be used to synthesize an inhibitor of glycinamide ribonucleotide formyltransferase.
    5-Bromo-3-fluoropicolinic acid
  • HY-W012313
    2,2'-Anhydrouridine
    		99.50%
    2,2'-Anhydrouridine (2,2'-Cyclouridine) is a nucleoside analog. 2,2'-Anhydrouridine is an important intermediate in the synthesis of other nucleoside-related compounds.
    2,2'-Anhydrouridine
  • HY-100705
    DMNB
    		98.56%
    DMNB (6-Nitroveratraldehyde), a precursor, can be used for the synthesis no-carrier-added 6-[18F]fluoro-L-DOPA (6-FDOPA). No-Carrier-Added (NCA) 6-[18F]fluoro-L-dopa (6-FDOPA) is being produced routinely for PET investigations of dopaminergic systems.
    DMNB
  • HY-12424A
    42-(2-Tetrazolyl)rapamycin
    42-(2-Tetrazolyl)rapamycin is a proagent compound of a rapamycin analog extracted from patent US 20080171763 A1, Example 1. Rapamycin is a specific mTOR inhibitor.
    42-(2-Tetrazolyl)rapamycin
  • HY-W018800
    4(3H)-Quinazolinone
    		99.89%
    4(3H)-Quinazolinone is a fused nitrogen heterocyclic compound whose derivatives have a wide range of antimicrobial and antitumor activities.
    4(3H)-Quinazolinone
  • HY-W003282
    3,6-Dibromo-2-methylpyridine
    		99.58%
    3,6-Dibromo-2-methylpyridine is a key intermediate in organic synthesis. 3,6-Dibromo-2-methylpyridine can be used in the study of pulmonary fibrosis and PRC2-dependent cancers.
    3,6-Dibromo-2-methylpyridine
  • HY-66004
    4-Acetamidophenyl acetate
    4-Acetamidophenyl acetate is an impurity of Acetaminophen (HY-66005). 4-Acetamidophenyl acetate acts as an intermediate in the synthesis of Acetaminophen. Acetaminophen is a selective COX-2 inhibitor (IC50=25.8 μM), and is a potent hepatic N-acetyltransferase 2 (NAT2) inhibitor.
    4-Acetamidophenyl acetate
  • HY-Y0188
    3-Bromobenzoic acid
    		99.93%
    3-Bromobenzoic acid is an important intermediate that can be used in the synthesis of other active compounds. 3-Bromobenzoic acid can react with a variety of electrophiles to generate a variety of 2-substituted-3-bromobenzoic acid derivatives. 3-Bromobenzoic acid is also an effective corrosion inhibitor for aluminum in alkalized Persian Gulf seawater and NaOH solution.
    3-Bromobenzoic acid
  • HY-145767A
    SN-38-CO-DMEDA TFA
    		98.07%
    SN-38-CO-DMEDA TFA is the intermediate product for synthesizing antibody-conjugated drug LND1035.
    SN-38-CO-DMEDA TFA
  • HY-W002860
    Cycloheptane-1,3-dione
    		99.73%
    Cycloheptane-1,3-dione (Compound 1A) is an intermediate. Cycloheptane-1,3-dione can be used to synthesize Compound 1-1. Compound 1-1 has anticancer activity against colon cancer.
    Cycloheptane-1,3-dione
  • HY-W002864
    6-Bromonicotinic acid
    		99.75%
    6-Bromonicotinic acid is a brominated derivative of Niacin (HY-B0143), can be used as a drug intermediate for the synthesis of Anabaseine (HY-115766) derivatives.
    6-Bromonicotinic acid
  • HY-32837
    5-Bromo-2-(hydroxymethyl)pyridine
    		99.95%
    5-Bromo-2-(hydroxymethyl)pyridine (5-Bromo-2-pyridinemethanol) is an important intermediate, which can be used for the synthesis of other active compounds.
    5-Bromo-2-(hydroxymethyl)pyridine
  • HY-W002314
    2-Bromo-4'-hydroxyacetophenone
    		98.59%
    2-Bromo-4'-hydroxyacetophenone is a PTP1B inhibitor with a Ki value of 42 μM. 2-Bromo-4'-hydroxyacetophenone is also an intermediate. 2-Bromo-4'-hydroxyacetophenone can be used in the synthesis of LXRα/β antagonists. 2-Bromo-4'-hydroxyacetophenone can be used in research on hematological diseases.
    2-Bromo-4'-hydroxyacetophenone
  • HY-128383
    1-Methylpyrrolidine
    		99.02%
    1-Methylpyrrolidine is a methylated pyrrolidine, which can be used as a precursor to synthesize polyfluorinated pyrrolidine derivatives.
    1-Methylpyrrolidine
  • HY-40226
    4-Amino-1-Boc-piperidine-4-carboxylic acid
    		≥98.0%
    4-Amino-1-Boc-piperidine-4-carboxylic acid serves as a key intermediate for constructing various bioactive compounds.
    4-Amino-1-Boc-piperidine-4-carboxylic acid
  • HY-W012618
    1-Phenyl-1-propanol
    		99.95%
    1-Phenyl-1-propanol is used as a chiral building block and synthetic intermediate in the pharmaceutical industries. 1-Phenyl-1-propanol is an intermediate of anti-depressant agent Fluoxetine (HY-B0102).
    1-Phenyl-1-propanol
  • HY-W014226
    4,4'-Dihydroxybenzophenone
    		99.82%
    4,4'-Dihydroxybenzophenone is a type of phenolic ultraviolet absorber and a drug intermediate for synthesis of various anticancer active compounds (such as Sivifene (HY-14801)). 4,4'-Dihydroxybenzophenone binds to the active site of trypsin with binding constants (KA = 7.59 x 105 L/moL) and leads to abnormal structure of trypsin, suggesting that long-term intake may affect the digestive function of the human body. 4,4’-dihydroxybenzophenone has a relatively low toxicity to Chlorella vulgaris and a moderate toxicity to Daphnia magna.
    4,4'-Dihydroxybenzophenone